Human epidermal growth factor receptor 2 (HER2)-specific CAR-T cells generated from patients with GBM effectively targeted HER2-positive GBM, suggesting a promising immunotherapeutic approach for GBM [44]. Here, ERBB2 is linked to glioblastoma.